Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#2114
AnaptysBio, Inc. - Common Stock
55.2
3
USD
-3.14%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.14%
Monthly Change
-12.39%
6 month change
+33.08%
Year Change
+56.90%
Previous Close
57.0
2
Open
55.5
4
Low
55.2
3
High
55.8
1
Volume
114
Markets
US Stock Market
Healthcare
ANAB
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
27.37 M
27.67 M
27.93 M
26.76 M
30.67 M
28.75 M
29.1 M
Valuation ratios
Enterprise value
337.92 M
465.89 M
744.84 M
544.79 M
282.95 M
1.16 B
1.49 B
Price to earnings ratio
—
-16.47
-6.39
-3.57
-2.59
-105.39
-58.63
Price to sales ratio
—
15.09
80
34.05
4.12
5.94
7.42
Price to cash flow ratio
—
-20.76
-11.18
-4.84
-2.78
70.78
363.21
Price to book ratio
—
2.67
3.14
6.63
5.3
37.47
-72.21
Enterprise value to EBITDA ratio
-14.49
-8.29
-6.51
-3.33
-2.47
23.85
36.09
Profitability ratios
Return on assets %
-0.05
-0.09
-0.21
-0.36
-0.3
-0.04
-0.16
Return on equity %
-0.05
-0.16
-0.49
-1.86
-2.05
-0.36
-4.15
Return on invested capital %
-238.66
-409.35
-360.47
-619.98
-899
1 195.61
-868.75
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-31.84
-89.93
-1 119.41
-958.27
-125.93
20.42
-135.53
EBITDA margin %
-31.09
-88.95
-1 112.85
-954.47
-125.27
20.65
-135.03
Net margin %
-26.57
-91.49
-1 251.33
-953.66
-159.1
-5.64
-206.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
20.01
34.4
17.16
10.87
9.51
9.07
7.58
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.18
0.12
0.02
0.03
0.19
0.64
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.67
-2.61
-4.49
-4.77
0.68
0.16
EBIT per share
—
-2.07
-4.09
-6.11
-4.05
1.67
1.41
EBITDA per share
—
-2.05
-4.06
-6.08
-4.03
1.68
1.43
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
19.98
15.67
14.52
13.58
10.84
9.98
Net current asset value per share
—
20.19
15.88
15.11
15.22
12.18
11.02
Tangible book value per share
—
12.99
9.31
3.27
2.5
1.29
0.44
Working capital per share
—
19.6
14.95
13.72
13.62
10.84
9.56
Book value per share
—
12.99
9.31
3.27
2.5
1.29
0.44
News
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?
Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)
AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down
TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View
Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised
AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy?